EMA Acknowledges “Possible Link” Between AstraZeneca Jab And Deadly Blood Clots

EMA Acknowledges “Possible Link” Between AstraZeneca Jab And Deadly Blood Clots

Update (1030ET): As the briefing continued, Reuters reported comments from the MHRA, the UK’s top pharmaceutical regulator, said the link between the blood clots and the AZ jab remains small. It reiterated that the benefits outweigh the risks. AstraZeneca is a British-Swedish company and the jab was mostly developed in the UK, with the help of Oxford, the storied British university.

The risk of rare blood clots from the AZ jab is about 1 in 1 million patients, the MHRA said.

* * *

Update (1020ET): As EMA officials, including the agency’s head, Emer Cooke, started answering questions, more reports hit the tape citing a document sent by the EMA to the health ministries of member states.

In it, EU health managers were reportedly urged to coordinate the use of the AstraZeneca jab, and to help stop “misinformation” from spreading. Health ministers were also told before the announcement that the EMA’s new findings might impact vaccination plans.

* * *

Update (0955ET): In a statement released just minutes before the briefing’s start, the EMA declared that it had found a possible link between the extremely rare blood clots and the AstraZeneca jab – however, these risks are still heavily outweighed by the societal benefits.

  • EMA FINDS POSSIBLE LINK TO VERY RARE CASES UNUSUAL BLOOD CLOTS
  • EMA CONFIRMS TOTAL BENEFIT-RISK REMAINS POSITIVE ON ASTRA SHOT
  • EMA: SPECIFIC RISK FACTORS NOT CONFIRMED FOR WOMEN UNDER 60
  • MOST CASES REPORTED WITHIN 2 WEEKS OF VACCINATION
  • IMMUNE RESPONSE ONE POSSIBLE EXPLANATION
  • EMA: COMBINATION OF BLOOD CLOTS AND LOW BLOOD PLATELETS IS RARE
  • EMA SAYS CONCLUDED TODAY THAT UNUSUAL BLOOD CLOTS WITH LOW BLOOD PLATELETS SHOULD BE LISTED AS VERY RARE SIDE EFFECTS OF VAXZEVRIA
  • EMA SAYS IN REACHING CONCLUSION, COMMITTEE TOOK INTO CONSIDERATION ALL CURRENTLY AVAILABLE EVIDENCE, INCLUDING THE ADVICE FROM AN AD HOC EXPERT GROUP
  • EMA: COMBINATION OF BLOOD CLOTS AND LOW BLOOD PLATELETS IS RARE

* * *

Weeks after its initial “safety review”, where the EMA insisted that the risks posed by the AstraZeneca jab were outweighed by the massive societal benefit, dozens of new cases of blood clots have been detected, including 25 in the UK that have apparently been linked to the jab. The news prompted Oxford to cancel a trial of the vaccine involving young children. Yesterday, the EMA finally acknowledged that there might indeed be a link between the jab and the clots, but that it wasn’t very clear.

Wednesday is “World Health Day”, yet two regions in Spain have just announced new plans to suspend AstraZeneca shots to patients under 65, pending further clarification from the EMA.

“EMA is holding a virtual press briefing on the conclusion of the evaluation of a safety signal with Vaxzevria (formerly Covid-19 Vaccine AstraZeneca) relating to cases of thromboembolic events by EMA’s safety committee,” the agency said in a statement.

A few days ago, an Australian official ackowledged that a link between the jab and the brain blood clots were extremely like.

Readers can watch the briefing live below:

Tyler Durden
Wed, 04/07/2021 – 11:05

ZeroHedge News

Leave a Reply